InterCure Ltd. Announces Proposed VoluntaryDelisting from the Toronto Stock Exchangeand shallcontinue to be listed on the NASDAQ and TASEroman4682Jul 9, 20240 min read07-10-2023.pdfDownload PDF • 186KB
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million,Strong Start to 2025
